Drawing for TRIALSIGHT

USPTO serial 99630447

TRIALSIGHT

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
FRIZALONE, SARAH O
Law office
TMO LAW OFFICE 112

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with TRIALSIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

NEELAM K SINGH

NEELAM K SINGH Singh Law Practice, LLC403 6th AvenueSuite 12Brooklyn, NY 11215

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Recruitment and placement of personnel in the field of clinical trialsACTIVEAug 1, 2025
042Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research in the nature of conducting clinical trials for others in the field of non-interventional early cancer and disease detection; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing information in the field of clinical research via a website; Providing a website featuring educational information in the field of clinical researchACTIVEAug 1, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 13, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 13, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 31, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2026DOCKASSIGNED TO EXAMINER—
May 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 3, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance